Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for BV in Low-Risk Pregnancy
NCT00153517Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Oct 1999
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Microbiological, Clinical, and Therapeutic Cure Rates. Started Oct 1999; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00153517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153517.